Although the frequencies of ASXL1, RUNX1, and SRSF2 are lower than 10% in the total cohort, we still took them into consideration cause they have been reported to strongly correlate with AML prognosis. The gene discussed is ASXL1; the disease is acute myeloid leukemia.